American International Group’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-18,950
Closed -$411K 3074
2017
Q2
$411K Buy
18,950
+2,944
+18% +$53.4K ﹤0.01% 1831
2017
Q1
$225K Sell
16,006
-2,458
-13% -$40.3K ﹤0.01% 2108
2016
Q4
$346K Sell
18,464
-244
-1% -$4.15K ﹤0.01% 1867
2016
Q3
$309K Sell
18,708
-825
-4% -$12.2K ﹤0.01% 1895
2016
Q2
$263K Buy
19,533
+369
+2% +$5.38K ﹤0.01% 1955
2016
Q1
$293K Buy
19,164
+925
+5% +$14.5K ﹤0.01% 2434
2015
Q4
$362K Sell
18,239
-6,573
-26% -$125K ﹤0.01% 2301
2015
Q3
$432K Buy
24,812
+1,201
+5% +$24.5K ﹤0.01% 2147
2015
Q2
$477K Buy
23,611
+5,909
+33% +$114K ﹤0.01% 2233
2015
Q1
$312K Buy
17,702
+119
+0.7% +$2.03K ﹤0.01% 2566
2014
Q4
$286K Sell
17,583
-508
-3% -$9.32K ﹤0.01% 2635
2014
Q3
$399K Buy
18,091
+596
+3% +$12.2K ﹤0.01% 2332
2014
Q2
$352K Buy
17,495
+1,676
+11% +$28.4K ﹤0.01% 2488
2014
Q1
$294K Buy
15,819
+380
+2% +$5.23K ﹤0.01% 2504
2013
Q4
$156K Sell
15,439
-155
-1% -$1.87K ﹤0.01% 2986
2013
Q3
$201K Buy
+15,594
New +$192K ﹤0.01% 2722

Other funds holding AMRI

American International Group's AMRI Position: Q3 2017 in Review

American International Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 18,950 shares — an estimated $411K sold.

American International Group first reported a position in AMRI in Q3 2013 and held it in 16 quarters. The position peaked at $477K in Q2 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • American International Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • American International Group sold 18,950 Albany Molecular Research Inc shares in Q3 2017, an estimated $411K.
  • American International Group first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 16 quarters.
  • American International Group's Albany Molecular Research Inc position peaked at $477K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on American International Group's 13F filing for Q3 2017, filed 9 Nov 2017.